草药和针对甲基胺的协同作用
Jin Gyeom Lee1,2, Yuchi Li3, Nam Jun Kim1,2
1Department of Acupuncture, Moxibustion and Acupoint, College of Korean Medicine, Daegu Haany University, Daegu, Republic of Korea.
Integrative medicine research
|September 2, 2024
概括
草药Ja-Geum-Jeong (JGJ) 通过激活中央杏仁体来抑制甲基胺 (METH) 的作用. 将JGJ与SI5针点的针结合起来,可以增强其对METH成的治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 综合医学是一个整体的医学.
背景情况:
- 草药Ja-Geum-Jeong (JGJ) 传统上用于东亚地区的排毒.
- 基于JGJ影响的确切机制,特别是关于药物滥用,仍然不清楚.
- 滥用甲基胺 (METH) 是一个重大的公共卫生挑战,需要新的治疗策略.
研究的目的:
- 研究JGJ对METH增强性能的抑制作用.
- 确定将JGJ与针结合是否产生对METH影响的协同效应.
- 阐明JGJ对METH诱导行为的行为背后的神经生物学机制.
主要方法:
- 在Sprague-Dawley大鼠中进行急性METH的使用,以评估运动活动和超声波发声 (USV).
- 在特定的针点 (HT7,SI5) 用口服和针给药JGJ.
- 中枢杏仁体 (CeA) 注射单谷氨酸 (MSG) 和胺黄油酸 (GABA) 激动剂;测量氨酸化酶 (TH) 和快速扫描循环电量计 (FSCV).
主要成果:
- JGJ显著抑制了METH诱导的运动活动和USV呼叫的增加.
- 在SI5针点的针,与JGJ结合,证明了对METH的作用的协同抑制作用.
- JGJ的抑制作用依赖于CeA的激活,MSG模仿了JGJ的作用.
- 神经化学和电生理学测量 (TH,FSCV) 证实了行为发现.
结论:
- JGJ对METH的强化特性表现出抑制作用,通过中央杏仁体的激活进行介导.
- 结合JGJ和针,特别是在SI5针点,为METH成提供了一种协同的治疗方法.
- 这项研究为JGJ的传统使用提供了神经生物学基础,并强调了它在药物使用障碍的现代药物治疗中的潜力.
更多相关视频
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
729
05:56Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
744
相关概念视频
01:27Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
01:23Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
01:28Adrenergic Agonists: Mixed-Action Agents
690
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
690
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
167
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
167
01:25Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K